The North America Diagnostic Analytics In Healthcare Industry Market is expected to witness market growth of 28.2% CAGR during the forecast period (2024-2031).
The US market dominated the North America Diagnostic Analytics in Healthcare Industry Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $16.27 billion by 2031. The Canada market is experiencing a CAGR of 30.9% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 29.8% during 2024-2031.
Diagnostic analytics has emerged as a transformative force in the healthcare industry, revolutionizing how diseases are detected, monitored, and managed. This data-driven methodology utilizes sophisticated tools and technologies to analyze intricate medical data, yielding actionable insights that substantially improve the efficiency and efficacy of healthcare delivery.
At its core, diagnostic analytics involves systematically analyzing diverse healthcare data, ranging from electronic health records (EHRs) and medical imaging to genomic and wearable device data. This capability has shifted the paradigm from reactive to proactive healthcare. Previously, diagnoses often relied on symptomatic presentations, which sometimes led to delayed interventions or suboptimal treatments.
Driven by rising healthcare spending and a developing private healthcare sector, Mexico is becoming a major player in the North American diagnostic analytics industry. The rising disease burden in Mexico underscores the urgent need for advanced healthcare solutions. Nearly 12.8 million Mexicans were diagnosed with diabetes in 2019, and this number is projected to escalate to 22.3 million by 2045, according to the National Library of Medicine. This alarming trend emphasizes the importance of digital tools, such as diagnostic analytics platforms and lifestyle disease management applications, in aiding patients and healthcare providers in monitoring and managing diabetes and related conditions effectively. Thus, the market across North America is marked by innovation and strong government support.
The US market dominated the North America Diagnostic Analytics in Healthcare Industry Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $16.27 billion by 2031. The Canada market is experiencing a CAGR of 30.9% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 29.8% during 2024-2031.
Diagnostic analytics has emerged as a transformative force in the healthcare industry, revolutionizing how diseases are detected, monitored, and managed. This data-driven methodology utilizes sophisticated tools and technologies to analyze intricate medical data, yielding actionable insights that substantially improve the efficiency and efficacy of healthcare delivery.
At its core, diagnostic analytics involves systematically analyzing diverse healthcare data, ranging from electronic health records (EHRs) and medical imaging to genomic and wearable device data. This capability has shifted the paradigm from reactive to proactive healthcare. Previously, diagnoses often relied on symptomatic presentations, which sometimes led to delayed interventions or suboptimal treatments.
Driven by rising healthcare spending and a developing private healthcare sector, Mexico is becoming a major player in the North American diagnostic analytics industry. The rising disease burden in Mexico underscores the urgent need for advanced healthcare solutions. Nearly 12.8 million Mexicans were diagnosed with diabetes in 2019, and this number is projected to escalate to 22.3 million by 2045, according to the National Library of Medicine. This alarming trend emphasizes the importance of digital tools, such as diagnostic analytics platforms and lifestyle disease management applications, in aiding patients and healthcare providers in monitoring and managing diabetes and related conditions effectively. Thus, the market across North America is marked by innovation and strong government support.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- Abbott Laboratories
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation
- Qiagen N.V
- Medtronic PLC
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Quest Diagnostics Incorporated
- GE HealthCare Technologies, Inc.
Market Report Segmentation
By Deployment Mode- Cloud-Based
- On-Premise
- Hybrid
- Clinical Data
- Medical Imaging Data
- Wearables & IoT Data
- Lab Test Data
- Genomic Data
- Hospitals
- Diagnostic Laboratories
- Clinics and Physician Practices
- Research & Academic Institutes
- Insurance Companies & Other
- Predictive Analytics
- Prescriptive Analytics
- Descriptive Analytics
- Diagnostic Analytics
- Artificial Intelligence (AI) & Machine Learning (ML)
- Big Data Analytics
- Cloud-Based Analytics
- Natural Language Processing (NLP)s
- Other Technology
- Disease Detection & Diagnosis
- Clinical Decision Support
- Personalized Treatment
- Radiology & Medical Imaging
- Patient Monitoring and Remote Diagnostics
- Other Application
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
Chapter 6. North America Diagnostic Analytics in Healthcare Industry Market by Data Source
Chapter 7. North America Diagnostic Analytics in Healthcare Industry Market by End-User
Chapter 8. North America Diagnostic Analytics in Healthcare Industry Market by Type
Chapter 9. North America Diagnostic Analytics in Healthcare Industry Market by Technology
Chapter 10. North America Diagnostic Analytics in Healthcare Industry Market by Application
Chapter 11. North America Diagnostic Analytics in Healthcare Industry Market by Country
Chapter 12. Company Profiles
Companies Mentioned
- Siemens Healthineers AG (Siemens AG)
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Qiagen N.V
- Medtronic PLC
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Quest Diagnostics Incorporated
- GE HealthCare Technologies, Inc.
Methodology
LOADING...
